Second Quarter 2021 Supplemental Financial Information July 29, 2021 labcorp CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Cautionary Statement Regarding Forward-Looking Statements This presentation of Laboratory Corporation of America Holdings contains forward-looking statements, statements with respect to (i) the estimated 2021 guidance and the related assumptions, (ii) the impact of various factors on operating and financial results, including the projected impact of the COVID-19 pandemic on ...

Laboratory Corporation of America Holdings (NYSE:LH) Q2 2021 Earnings Conference Call July 29, 2021 9:00 AM ET Company Participants Chas Cook - IR Adam Schechter - President, CEO & Chairman Glenn Eisenberg - CFO & EVP Conference Call Participants Brian Tanquilut - Jefferies Jack Meehan - Nephron Research Kevin Caliendo - UBS Ricky Goldwasser - Morgan Stanley Ralph Giacobbe - Citigroup Justin Bowers - Deutsche Bank Tycho Peterson - JPMorgan Derik De Bruin - Bank of America Matt Larew - William Blair Aaron Wr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-37573 ...

Laboratory Corporation of America Holdings (NYSE:LH) Q1 2021 Earnings Conference Call April 29, 2021 9:00 AM ET Company Participants Chas Cook - IR Adam Schechter - President, CEO & Chairman Glenn Eisenberg - CFO & EVP Conference Call Participants Jack Meehan - Nephron Research Erin Wright - Crédit Suisse Dan Leonard - Wells Fargo Securities Kevin Caliendo - UBS Ralph Giacobbe - Citigroup Ricky Goldwasser - Morgan Stanley Brian Tanquilut - Jefferies Matthew Larew - William Blair & Company Derik De Bruin - B ...

Index UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [☒] Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 or [☐] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ______ to ______ Commission file number - 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 1 ...

Laboratory Corporation of America Holdings (NYSE:LH) Q4 2020 Earnings Conference Call February 11, 2021 9:00 AM ET Company Participants Clarissa Willett - VP, IR Adam Schechter - Chairman and CEO Glenn Eisenberg - EVP and CFO Conference Call Participants Jack Meehan - Nephron Research Dan Leonard - Wells Fargo Lisa Gill - JPMorgan Erin Wright - Crédit Suisse Ralph Giacobbe - Citi Eric Coldwell - Baird Eugene Kim - Wolfe Research Pito Chickering - Deutsche Bank Adam Noble - UBS Ricky Goldwasser - Morgan Stan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-3 ...

Laboratory Corporation of America Holdings (NYSE:LH) Q3 2020 Earnings Conference Call October 27, 2020 9:00 AM ET Company Participants Clarissa Willett - VP, IR Adam Schechter - President, CEO & Chairman Glenn Eisenberg - CFO & EVP Conference Call Participants Jack Meehan - Nephron Research Philip Chickering - Deutsche Bank Erin Wilson - Crédit Suisse Kevin Caliendo - UBS Investment Bank Lisa Gill - JPMorgan Chase & Co. Eric Coldwell - Robert W. Baird & Co. Donald Hooker - KeyBanc Capital Markets Brian Tanq ...

THIRD QUARTER 2020 SUPPLEMENTAL FINANCIAL INFORMATION OCTOBER 27, 2020 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS 1 This presentation of Laboratory Corporation of America Holdings (the "Company") contains forward-looking statements, including, but not limited to, statements with respect to expectations for 2020 and the related assumptions, the impact of various factors on operating and financial results, including the projected impact of the COVID-19 pandemic on the Company's businesses, oper ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 1-11353 LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact name of registrant as specified in its charter) | Delaware | | 13-375737 ...